Changes of Nocturnal Blood Pressure Dipping Status in Hypertensives by Nighttime Dosing of α-Adrenergic Blocker, Doxazosin: Results from the HALT Study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Abstract —Abnormal nocturnal blood pressure (BP) dipping status may be partly determined by nocturnal sympathetic activity. We studied the effect of nighttime dosing of an α 1 -adrenergic blocker, doxazosin, on the BP dipping status of 118 hypertensives, all of whom underwent 24-hour ambulatory BP monitoring before and after treatment. The mean nighttime/daytime ratio of systolic BP was increased (0.91 after therapy versus 0.89 at baseline, P <0.05). The patients were initially divided into 4 groups on the basis of their dipping status at the baseline assessment: 18 (15%) were extreme dippers, with a nighttime systolic BP fall of at least 20% of daytime BP; 46 (39%) were dippers (fall between 10% and 20%); 48 (41%) were nondippers (fall between 0% and 10%); and 6 (5%) were risers (nocturnal increase of systolic BP). A shift in dipping status toward less nocturnal BP dipping was observed after doxazosin therapy ( P <0.05). Dipping status was determined by nighttime more than by daytime BP, and this was not explained by differences in the number of daytime and nighttime readings. The effects of doxazosin on the mean nocturnal systolic BP changes were an increase of 4.3 mm Hg in extreme dippers and decreases of 0.7 mm Hg in dippers, 12 mm Hg in nondippers, and 18 mm Hg in risers; the reduction was only significant in the latter 2 groups (both P <0.01). To estimate the effects of regression to the mean on the changes in dipping status, we also defined dipping status with the average of the BPs before and after doxazosin and found no difference in the degree of nighttime BP reduction among each group. The reduction of daytime BP was now significantly greater in the subgroups with less dipping: 6.4 mm Hg for extreme dippers and 16 mm Hg for risers ( P <0.05). In conclusion, nighttime dosing with doxazosin markedly affects the nocturnal BP dipping status of hypertensives, but the apparently greater reduction in nighttime pressure in nondippers and risers may be, at least partly, due to the effect of regression to the mean. The most important determinants of the effect of doxazosin were the absolute BP levels, both day and night, rather than dipping status per se.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic-Nerve Activity during Sleep in Normal Subjects
Somers, V. K., Dyken, M. E., Mark, A. L., & Abboud, F. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280502 · Cited by 1,574 · cited 1×
“Doxazosin 123 (18) 128 (15) 133 (16) 134 (18)”
Cited by
Regression to the mean: what it is and how to deal with it
Barnett, A. G. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh299 · Cited by 1,988
Gangwisch, J. E., Heymsfield, S. B., Boden-Albala, B., Buijs, R. M., Kreier, F., Pickering, T. G., Rundle, A. G., Zammit, G. K., & Malaspina, D. (2006) · Hypertension · doi:10.1161/01.hyp.0000217362.34748.e0 · Cited by 1,284
Self-citationStroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives
Kario, K., Pickering, T. G., Matsuo, T., Hoshide, S., Schwartz, J. E., & Shimada, K. (2001) · Hypertension · doi:10.1161/hy1001.092640 · Cited by 759
Self-citationMeng, L., Zheng, Y., & Hui, R. (2013) · Hypertension Research · doi:10.1038/hr.2013.70 · Cited by 370
Nocturnal blood pressure and cardiovascular disease: a review of recent advances
Yano, Y., & Kario, K. (2012) · Hypertension Research · doi:10.1038/hr.2012.26 · Cited by 227
Self-citationChoi, K. M., Lee, J. S., Park, H. S., Baik, S. H., Choi, D. S., & Kim, S. M. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.62 · Cited by 169
Kario, K., Shin, J., Chen, C., Buranakitjaroen, P., Chia, Y., Divinagracia, R., Nailes, J., Hoshide, S., Siddique, S., Sison, J., et al. (2019) · The Journal of Clinical Hypertension · doi:10.1111/jch.13652 · Cited by 164
Self-citationCuspidi, C., Sala, C., Tadic, M., Gherbesi, E., De Giorgi, A., Grassi, G., & Mancia, G. (2017) · The Journal of Clinical Hypertension · doi:10.1111/jch.13023 · Cited by 127
A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease
Rahman, M., Greene, T., Phillips, R. A., Agodoa, L. Y., Bakris, G. L., Charleston, J., Contreras, G., Gabbai, F., Hiremath, L., Jamerson, K., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.200477 · Cited by 93
KURODA, T., KARIO, K., HOSHIDE, S., HASHIMOTO, T., NOMURA, Y., SAITO, Y., MITO, H., & SHIMADA, K. (2004) · Hypertension Research · doi:10.1291/hypres.27.15 · Cited by 70
Self-citationLiu, J., Su, X., Nie, Y., Zeng, Z., & Chen, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.755403 · Cited by 16
Metadata
- Authors
- Kario, K., Schwartz, J. E., & Pickering, T. G.
- Venue
- Hypertension
- Published
- 2000-03
- Volume
- 35
- Issue
- 3
- Pages
- 787-794
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2070673056
- Cited by
- 163
- References
- 1
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.